Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer, Wyeth Post Lackluster Sales as They Prepare for a Future Together

Executive Summary

Pfizer's new business units - which are key to transforming the company - came under Wall Street scrutiny as the company for the first time broke down first quarter sales per unit in an earnings report released April 28

You may also be interested in...



Health Care Reform For Pfizer Equals $800 Million Revenue Hit In 2012

The addition of legacy Wyeth products helped cushion Pfizer's top-line in the first quarter, and synergies stemming from the integration could help the company absorb the cost of health care reform

Health Care Reform For Pfizer Equals $800 Million Revenue Hit In 2012

The addition of legacy Wyeth products helped cushion Pfizer's top-line in the first quarter, and synergies stemming from the integration could help the company absorb the cost of health care reform

Health Care Reform For Pfizer Equals $800 Million Revenue Hit In 2012

Pfizer maintained its 2012 earnings per share guidance, despite the lower revenue projections, however.

Related Content

Topics

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel